Vivolux was founded in Sweden in 2004 with a focus on the development of novel cancer drugs based on phenotypic models, where the unique behavior of malignant cells under specific conditions is utilized to identify new targets and molecules acting on these targets. Working in close collaboration with research groups at Uppsala University and the Karolinska Institute, Vivolux has developed a unique and comprehensive system for preclinical analysis of cancer drugs, including tests on primary cultures of human cancer cells, cells grown in three-dimensional aggregates and methods for molecular investigation of mechanism of action. Several drug candidates have been identified and optimized and the results from these investigations have been published in international scientific journals. Two novel drugs with new mechanisms of action for cancer treatment are currently undergoing clinical investigation in collaboration with leading cancer institutes in the USA. In 2014, Vivolux Inc. was established in the USA.
View Top Employees from Vivolux AB| Website | http://www.vivolux.com |
| Revenue | $5 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2006 |
| Address | 20130 Lakeview Center Plz, Ste 400, Ashburn, Virginia 20147, US |
| Phone | (703) 840-5474 |
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Vivolux AB employee's phone or email?
Vivolux AB Questions
The Vivolux AB annual revenue was $5 million in 2024.
1 people are employed at Vivolux AB.
Vivolux AB is based in Ashburn, Virginia.
The NAICS codes for Vivolux AB are [5417, 541, 541714, 54, 54171].
The SIC codes for Vivolux AB are [87, 873].
